Abstract
To achieve therapeutic effects, gene transportation or gene transfection becomes the key technique of gene therapy. Since viral vectors for gene therapy have shown serious problems, including immunogenicity and other adverse effects, non-viral carriers have attracted a great deal of attention, despite the fact that the transfection efficiencies are lower than those by viral carriers. Therefore, the major challenge of gene delivery is to improve the transfection efficiencies of the non-viral carriers, and first of all, the cell penetration efficiencies. This review focuses on recent approaches in the development of new non-viral gene delivery vectors, with great respect to those constructed based on cell penetration pathways of intracellular process considering transfection efficiency and cell penetration efficiency. Further development of sophisticated delivery systems is prospected for the non-viral vectors application in gene therapy.
Keywords: Gene delivery, Transfection efficiency, Pharmaceutical strategies, Non-viral vector, Cell penetration pathways
Current Gene Therapy
Title: Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Volume: 9 Issue: 4
Author(s): Chunxi Liu and Na Zhang
Affiliation:
Keywords: Gene delivery, Transfection efficiency, Pharmaceutical strategies, Non-viral vector, Cell penetration pathways
Abstract: To achieve therapeutic effects, gene transportation or gene transfection becomes the key technique of gene therapy. Since viral vectors for gene therapy have shown serious problems, including immunogenicity and other adverse effects, non-viral carriers have attracted a great deal of attention, despite the fact that the transfection efficiencies are lower than those by viral carriers. Therefore, the major challenge of gene delivery is to improve the transfection efficiencies of the non-viral carriers, and first of all, the cell penetration efficiencies. This review focuses on recent approaches in the development of new non-viral gene delivery vectors, with great respect to those constructed based on cell penetration pathways of intracellular process considering transfection efficiency and cell penetration efficiency. Further development of sophisticated delivery systems is prospected for the non-viral vectors application in gene therapy.
Export Options
About this article
Cite this article as:
Liu Chunxi and Zhang Na, Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems, Current Gene Therapy 2009; 9 (4) . https://dx.doi.org/10.2174/156652309788921053
DOI https://dx.doi.org/10.2174/156652309788921053 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Selective High Affinity Antagonists, Agonists, and Radioligands for the P2Y1 Receptor
Combinatorial Chemistry & High Throughput Screening The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Current Pharmaceutical Design Role of microRNAs on Blood Brain Barrier Dysfunction in Vascular Cognitive Impairment
Current Drug Delivery Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Current Pharmaceutical Design Monocarboxylate Transporter 1 in Brain Diseases and Cancers
Current Drug Metabolism The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment
Current Pharmaceutical Design Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Stage Regimen
Current Pharmaceutical Design Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
Current Clinical Pharmacology Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue: Engineered Magnetic Core@Shell Structures)
Current Pharmaceutical Design PI-3 Kinase-PTEN Signaling Node: An Intercept Point for the Control of Angiogenesis
Current Pharmaceutical Design Intraoperative Targeted Optical Imaging: A Guide towards Tumor-Free Margins in Cancer Surgery
Current Pharmaceutical Biotechnology Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
Current Neuropharmacology Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress
Current Topics in Medicinal Chemistry Immunologic Diseases and Brain Tumors
Inflammation & Allergy - Drug Targets (Discontinued) Cancer Stem Cells in Pediatric Brain Tumors
Current Stem Cell Research & Therapy Gold Nanoparticles in Cancer Therapy: Efficacy, Biodistribution, and Toxicity
Current Pharmaceutical Design TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design